§ 40-21-3. Preferred drug list.
(a) If a patient's healthcare provider prescribes a prescription drug that is not on the
preferred drug list, the prescriber shall consult with the program to confirm that,
in his or her reasonable professional judgment, the patient's clinical condition is
consistent with the criteria for approval of the nonpreferred drug. Such criteria
shall include:
(1) The preferred drug has been tried by the patient and has failed to produce the desired
health outcomes;
(2) The patient has tried the preferred drug and has experienced unacc
Free access — add to your briefcase to read the full text and ask questions with AI
§ 40-21-3. Preferred drug list.
(a) If a patient's healthcare provider prescribes a prescription drug that is not on the
preferred drug list, the prescriber shall consult with the program to confirm that,
in his or her reasonable professional judgment, the patient's clinical condition is
consistent with the criteria for approval of the nonpreferred drug. Such criteria
shall include:
(1) The preferred drug has been tried by the patient and has failed to produce the desired
health outcomes;
(2) The patient has tried the preferred drug and has experienced unacceptable side effects;
(3) The patient has been stabilized on a nonpreferred drug and transition to the preferred
drug would be medically contraindicated; or
(4) Other clinical indications identified by the committee for the patient's use of the
nonpreferred drug, which shall include consideration of the medical needs of special
populations, including children, elderly, chronically ill, persons with mental health
conditions, and persons affected by HIV/AIDS.
(b) In the event that the patient does not meet the criteria in subsection (a), the prescriber
may provide additional information to the program to justify the use of a prescription
drug that is not on the preferred drug list. The program shall provide a reasonable
opportunity for a prescriber to reasonably present his or her justification of prior
authorization. If, after consultation with the program, the prescriber, in his or
her reasonable professional judgment, determines that the use of a prescription drug
that is not on the preferred drug list is warranted, the prescriber's determination
shall be final.